Fresh Recalls

FDAClass II · Drug · Recall D-0526-2026 · Recalled May 6, 2026

Alendronate Sodium Oral Solution recall — Hikma Pharmaceuticals USA INC

Agency report date: May 6, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Alendronate Sodium Oral Solution
Company / brand
Hikma Pharmaceuticals USA
Lot / serial / date codes
Lot # AC2040A, Exp Date: 04/2026
Distribution
US Nationwide.
Agency product description and boundaries

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Alendronate Sodium Oral Solution recall status

3. Open the official notice or contact

Official recall ID
D-0526-2026
Brand
All Hikma Pharmaceuticals USA recalls
Classification
Class II
Units affected
4 single dose 75 ml bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Columbus, OH, United States
Firm address
1809 Wilson Rd, 43228-9579

Identifying details (verbatim from the notice)

Product codes / lots
Lot # AC2040A, Exp Date: 04/2026
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
98744
Recall initiated
April 7, 2026
FDA classified
May 8, 2026
FDA report date
May 6, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 4, 2026 at 11:00 PM UTC.

Report a data error on this page